Publication details

Myopia Control in European Children - Study Protocol and Methodology

Authors

KOMÍNEK Martin AUTRATA Rudolf KREJČÍŘOVÁ Inka ŽAJDLÍKOVÁ Barbora HEISSIGEROVÁ J. KORBASOVÁ M. STUDENÝ P. DOSTÁLEK M. HLOŽÁNEK M. UNAR VINKLEROVÁ Jana

Year of publication 2022
Type Article in Periodical
Magazine / Source HSOA Journal of Neonatology and Clinical Pediatrics
MU Faculty or unit

Faculty of Medicine

Citation
Web MARS
Doi http://dx.doi.org/10.24966/NCP-878X/100096
Keywords Atropine eye drops; Axial length of eye; Low dose atropine; Myopia in children; Progressive myopia
Description Purpose To report study protocol and methodology of multicentre, Randomized, double-blind, placebo-controlled study of the efficacy and safety of low dose atropine eye drops (0.02%, 0.04%) in slowing the progression of short-sightedness (myopia) in children. M.A.R.S. (Myopia and Atropin ReStriction). Conclusion M.A.R.S. clinical trial will enrich the knowledge about myopia and its possible treatment in the early stages in European children. It will be beneficial for paediatric patients, practicing paediatricians and ophthalmologist. In the future it will be helpful not only from a medical point of view, but also in economic aspect of management of progression of myopia in children and all the entire population.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info